Several authors have already shown that TG2 activity is increased in patients afflicted with Alzheimer’s disease (AD) and HD as compared to healthy subjects, which suggests that TG2 activity may contribute to the detrimental effects observed in affected individuals [33,34,35]. The gene discussed is TGM2; the disease is early-onset autosomal dominant Alzheimer disease.